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Abstract 24 
The T7 bacteriophage RNA polymerase (T7 RNAP) serves as a model for understanding RNA synthesis, as 25 
a tool for protein expression, and as an actuator for synthetic gene circuit design in bacterial cells and 26 
cell-free extract.  T7 RNAP is an attractive tool for orthogonal protein expression in bacteria owing to its 27 
compact single subunit structure and orthogonal promoter specificity.  Understanding the mechanisms 28 
underlying T7 RNAP regulation is important to the design of engineered T7-based transcription factors, 29 
which can be used in gene circuit design.  To explore regulatory mechanisms for T7 RNAP-driven 30 
expression, we developed a rapid and cost-effective method to characterize engineered T7-based 31 
transcription factors using cell-free protein synthesis and an acoustic liquid handler.  Using this method, 32 
we investigated the effects of the tetracycline operator’s proximity to the T7 promoter on the regulation 33 
of T7 RNAP-driven expression.  Our results reveal a mechanism for regulation that functions by 34 
interfering with the transition of T7 RNAP from initiation to elongation and validates the use of the 35 
method described here to engineer future T7-based transcription factors.   36 
Highlights 37 
• Development of a rapid and cost-effective method for screening synthetic promoters. 38 
• Insights into the regulation of engineered T7-based transcription factors and T7 RNAP enzyme 39 
kinetics.  40 
• Validation of this method by comparison with the T7 RNAP kinetic model. 41 
 42 
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Introduction 46 
Since its isolation in 1970 [1], the T7 bacteriophage RNA polymerase (T7 RNAP) has become a model for 47 
understanding RNA synthesis, as well as emerging as an important tool for protein expression [2] and as 48 
an actuator for synthetic gene circuit design in bacterial cells and cell-free extract [3,4].  The T7 RNAP is 49 
a 98 kDa, single-subunit enzyme that requires no additional protein factors to perform the complete 50 
transcriptional cycle [5].  This transcriptional cycle can be broken into three phases: binding, initiation, 51 
and elongation.  During binding, T7 RNAP specifically recognizes the T7 promoter [5], and it has little 52 
affinity for other sequences, even the closely-related T3 promoter [6].  T7 RNAP then performs several 53 
rounds of abortive transcription, producing transcripts 10-12 nucleotides in length [7,8].  The enzyme 54 
undergoes a conformational change that marks its transition from initiation to the highly-processive 55 
elongation phase [9], transcribing RNA at a rate of 43 nucleotides per second [10], and producing 56 
transcripts greater than 10 kb in size [11].  Comparing these characteristics with the native Escherichia 57 
coli RNAP, which requires multiple subunits and recognizes orthogonal promoters, demonstrates the 58 
utility of T7 RNAP as an orthogonal tool.  T7 RNAP was exploited early and often in synthetic gene circuit 59 
design owing to its ability to partially insulate circuit function from the host metabolism [3,4,12–14].  On 60 
average, there are only 2,000 native RNAP molecules per E. coli cell [15], and thus, the fluctuation of 61 
intracellular resources and variation in drag on metabolism, corresponding with growth phase and 62 
conditions, can complicate the predicted function of a gene circuit.  Having an orthogonal tool set of 63 
well-characterized actuators, such as T7 RNAP, is vital to the ability to accurately predict gene circuit 64 
function [12].  65 
One major drawback of the T7 RNAP system is the lack of regulatory mechanisms, beyond regulating the 66 
expression level of T7 RNAP, and a small set of synthetic promoters [4].  This stands in stark contrast to 67 
the large libraries of available and regulatable native promoters, including sets that are highly 68 
characterized and lack crosstalk [16].  Understanding regulatory mechanisms for T7 RNAP is important 69 
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to the discovery of new engineered T7-based transcription factors that can be used in gene circuit 70 
design.  Here we developed a rapid and cost-effective method to characterize promoter-operator 71 
combinations using cell-free protein synthesis and an acoustic liquid handler.  We chose, as a model to 72 
test this method, the tetracycline regulatory (tet) system.  The tet system functions to regulate protein 73 
expression when the homodimeric tetracycline repressor protein (TetR) binds to the tetracycline 74 
operator (tetO) sequence, resulting in downregulated transcription [17,18].  The tet system has been 75 
exploited in synthetic gene circuit design to regulate both host RNAP and T7 RNAP-driven expression 76 
[4,17,19–22].  In the case of host RNAP regulation, the tetO sequence can be placed between the -10 77 
and -35 regions, resulting in relatively greater dynamic ranges when compared with T7 RNAP regulation 78 
by the same system [23].  Due to the single binding region of the T7 promoter, the tetO sequence can 79 
only be placed up or downstream from the T7 promoter.  Thus, we investigated the effects of proximity 80 
of the tetO sequence to the T7 promoter on the regulation of T7 RNAP-driven expression.  81 
We show that, irrespective of the position of tetO within the first 13 bp downstream of the T7 promoter, 82 
T7 RNAP-driven expression is downregulated equally by TetR.  Conversely, placing the tetO sequence 83 
upstream from the T7 promoter shows nearly equal expression in the presence or absence of TetR.  Our 84 
results suggest that tet regulation of T7 RNAP occurs by interfering with the initiation phase of T7 RNAP.  85 
We believe that this finding reveals characteristics regarding regulation of T7 RNAP that can be used in 86 
the engineering of T7-based transcription factors, and that such engineered transcription factors can be 87 
rapidly characterized by the methods described herein.  88 
Materials and Methods 89 
PCR-Amplification of Linear Template 90 
Linear template for use in cell-free protein synthesis was amplified in two rounds of PCR using a single 91 
universal reverse primer and a set of two overlapping forward primers (one for each round of PCR) 92 
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containing different positional pairings of T7-tetO sequences.  PCR products were isolated by the Qiagen 93 
gel purification kit (Qiagen), quantified using a nanodrop spectrophotometer, diluted to 20 nM, and 94 
stored at -20°C until use (Fig. S2).  95 
Cloning of Linear Constructs into PY71 96 
Linear templates for each tetO position were PCR-amplified using forward and reverse primers to add 97 
homology regions to the 5’ and 3’ ends in order to facilitate seamless cloning into the pY71 vector (Fig. 98 
S1).  Linear templates were cloned into the pY71 vector using the In-fusion seamless cloning kit 99 
(Clontech).  Circular templates were amplified in E. coli DH5α cells and isolated by Qiagen miniprep kit 100 
(Qiagen), quantified using a nanodrop spectrophotometer, diluted to 20 nM, and stored at -20°C until 101 
use. 102 
Preparation of Cell-Free Extract and Cell-Free Reactions 103 
Cell-free extract was prepared according to Sun et al. [24] with the modification that cells were lysed by 104 
French pressure cell at 10,000 psi rather than by bead beating.  Cell-free reactions were prepared 105 
according to Sun et al. [24].  Except where noted, a reaction contained energy buffer (3.3 µL), extract 106 
(4.2 µL), T7 polymerase (0.12 µL from 13 mg/mL stock), malachite green (0.2 µL from 10 mM stock), 107 
GamS (0.15 µL from 207 µM stock), DNA template (1 µL), and water (0.03 µL).  Reactions were 108 
distributed by electronic pipette and TetR dilutions were distributed into cell-free reactions in volumes 109 
of 1 µL using an Echo 525 acoustic liquid handler (Labcyte Inc.). 110 
sfGFP expression, in a total volume of 10 µL, was measured in black, clear-bottom 384 well plates 111 
(Greiner).  Reactions were performed at 30°C and terminated after 12 h.  sfGFP expression was 112 
measured by fluorescence in a Biotek H1 plate reader at 415 nm (ex) / 528 nm (em).  Where indicated, 113 
RFU values were converted to protein concentration using calibration curves generated with purified 114 
sfGFP (a gift from Scott Walper, Naval Research Lab).  115 
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Purification of TetR Protein 116 
The tetR gene was PCR amplified from E. coli DH5α total DNA and seamlessly cloned into a pET-22B 117 
vector containing a C-terminal hexahistidine tag and expressed in E. coli BL21(DE3) cells.  Cells (1 g) were 118 
resuspended in lysis buffer (5 mL) (50 mM Tris-Cl, 500 mM NaCl, 5 mM imidazole, pH 8.0) and lysed by 119 
sonication.  The lysate was clarified by centrifugation at 15,000 x g for 30 minutes at 4°C.  The 120 
supernatant (5 mL) was mixed with Ni-NTA resin (1 mL) (Sigma Aldrich), incubated at 4°C for 1 h, and 121 
loaded into a column.  The resin was washed with 10 column volumes of wash buffer (50 mM Tris-Cl, 122 
500 mM NaCl, 25 mM imidazole, pH 8.0).  TetR was collected with three column volumes of elution 123 
buffer (50 mM Tris-Cl, 500 mM NaCl, 250 mM imidazole, pH 8.0) and concentrated to 1.5 mL using a 3 124 
kDa cut-off centrifugal concentrator (Millipore).  TetR was dialyzed against 2 L of dialysis buffer (50 mM 125 
NaHPO
4
, 100 mM NaCl, 2% DMSO, pH 7.5) for 1 h at 4°C then 2 L of dialysis buffer overnight at 4°C.  TetR 126 
was then centrifuged at 14,000 x g for 10 minutes to remove precipitate and quantified by absorbance 127 
at 280 nm using the molar extinction coefficient (15,845 M
-1
 cm
-1
).  Working TetR dilutions were first 128 
prepared, using dialysis buffer, by serial dilution, then flash frozen to reduce error and stored at -80°C 129 
until use.  130 
Purification of GamS Protein 131 
The GamS protein was expressed from the pBad vector according to Sun et al. [25] and purified by nickel 132 
affinity as described for the TetR protein.  GamS was dialyzed against 2 L of dialysis buffer (50 mM 133 
NaHPO
4
, 1 mM DTT, 1 mM EDTA, 100 mM NaCl, 2% DMSO, pH 7.5) for 1 h at 4°C then 2 L of dialysis 134 
buffer overnight at 4°C.  GamS was then centrifuged at 14,000 x g for 10 minutes to remove precipitate 135 
and quantified by absorbance at 280 nM using the molar extinction coefficient (11,460 M
-1
 cm
-1
).  GamS 136 
was diluted in dialysis buffer to 207 µM, flash frozen in liquid nitrogen, and stored at -80°C until use. 137 
Purification of T7 RNA Polymerase 138 
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T7 RNAP was expressed and purified according to Swartz et al. [26].  T7 RNAP was diluted to 13 mg/mL, 139 
flash frozen in liquid nitrogen, and stored at -80°C until use. 140 
Curve Fitting and Statistical Analysis 141 
sfGFP expression curves were fit to a sigmoidal equation: 142 
                                                   143 
Four parameter logistic regressions were performed using Prism software (Graphpad).  The maximum 144 
repression value for each construct was expressed as the difference between the top and bottom values145 
determined by the four parameter logistic fit. 146 
Statistical analysis was performed by a one-way ANOVA test, a two-way ANOVA test, or by Welch’s t-147 
test, as indicated in the results and figures, using Prism software (Graphpad).  For ANOVA tests, Tukey’s 148 
method was applied to determine statistical significance between data at each tetO position. 149 
Results 150 
TetO Represses T7 RNAP Equally when It is Positioned within the First 13 Bases of the T7 Transcript 151 
In order to effectively explore and understand the design space of engineered T7-based transcription 152 
factors, we aimed to develop a method that would allow for rapid and cost-effective characterization of 153 
promoter-operator combinations.  To do this, we generated linear template by PCR-amplifying the sfGFP154 
gene from the sfGFP-containing pY71-GFP plasmid using one universal reverse primer and different 155 
forward primers containing spatial combinations of T7-tetO across a stretch of standard base pairs (Fig. 156 
S2 and S3).  We chose the tetO
2
 sequence for this work because TetR has shown approximately twice 157 
the affinity for tetO
2
 over tetO
1 
[27].  We chose cellCfree extract, which is prepared from E. coli cells, in-158 
house, as a rapid and cost-effective medium for the measurement of protein expression [24,25].  This 159 
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method circumvents the need to clone, transform, and measure expression in whole cells, allowing for 160 
the characterization of many promoter-operator combinations in a single day.  Additionally, it allowed 161 
us to directly probe the effects of the tetO position using purified TetR.  For nomenclature purposes, 162 
constructs were designated according to the number of base pairs that the 5’ end of the tetO sequence 163 
lies away from the transcriptional start site of the T7 promoter sequence (or the length of the transcript, 164 
in bases) (Fig. S3).  165 
In order to prevent the degradation of linear template, GamS protein was added to the reaction mixture 166 
[25].  Different concentrations of TetR were added to reaction wells using an acoustic liquid handler.  167 
Cell-free reactions were run for 12 h, expression curves were fit using a sigmoidal regression, and the 168 
maximum sfGFP expression values were used for further evaluation (Fig. 1A). 169 
0.0
0.5
1.0
0.001 0.01 0.1 1
TetR, M
0
 
Figure 1. GFP Expression and TetR Dose-Response from Linear Template.  (A) GFP was expressed from 
2 nM linear tet.I.3 template in 10 µL of cell-free extract containing varying concentrations of TetR.  Each 
trace represents the mean and standard deviation of three reactions.  (A, inset) The expression curves 
shown in panel A were fit to a sigmoid regression.  The maximum expression values were rescaled and 
plotted against TetR concentration and a four parameter logistic curve fit was applied.  (B) The same 
analysis was performed for each tetO position and only the fits are shown. 
 170 
Despite that the same concentration of template was added to each reaction, we observed variation in 171 
the maximum sfGFP expression using different templates, ranging from 0.4 µM to 1.4 µM, in the 172 
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absence of TetR (Fig. S4A).  To determine whether these fluctuations were simply due to the positioning 173 
of the tetO sequence, we tested two different preparations of each template with no TetR present (Fig. 174 
S4A).  When a one-way ANOVA test was applied to the expression data from lot 1, no apparent pattern 175 
that might indicate an effect of the tetO position on expression became apparent (Fig. S4C).  A two-way 176 
ANOVA test was applied to the expression data of both lots in order to determine statistical significances 177 
in the difference in expression at each tetO position.  A pattern indicating no significance, running along 178 
the diagonal in Figure S4E, would illustrate the reproducibility of the variation in expression between 179 
lots (Fig. S4A).  However, such a pattern does not emerge, suggesting that variation cannot be explained 180 
by the tetO position alone.  181 
In order to facilitate direct comparisons between each tetO position, all mean expression values were 182 
divided by the greatest mean expression value for that position.  This transformation rescaled the 183 
expression data to a maximum value of one for each position.  Rescaled expression values were then 184 
plotted against the TetR concentration to generate dose-response profiles for each tetO position (Fig. 185 
1A, inset).  Each dose-response profile was fit to a four parameter logistic regression curve (Fig. 1B) in 186 
order to obtain maximum repression values and 1/2 inhibitory concentration (IC
50
) values for TetR for 187 
each construct (Table S1). 188 
A one-way ANOVA test comparing IC
50
 values at each position, revealed no significant difference (P ≤ 189 
0.0001), with the exception being that of tet.I.17, comparatively to other tetO positions (Fig. 2A).  190 
However, this may be explained by the difficulty in fitting the dose-response profile for tet.I.17, resulting 191 
in a large standard deviation (Fig. 2A).  These results suggest that there is no effect of the tetO position 192 
on TetR binding, using linear template.  193 
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Figure 2. The Effect of tetO Position and Template Type on T7-Driven Expression in Cell-Free Extract. 
(A) The TetR IC
50
 values for each construct, calculated from the four parameter logistic curve fits (Fig. 1 
and 3) were plotted against tetO position.  Each trace represents the mean and standard deviation of 
three replicates.  (B) The maximum repression values for each construct, calculated by subtracting the 
minimum value from the maximum value for each logistic curve fit (Fig. 1B and 3B) were plotted against 
tetO position.  Each trace represents the mean and standard deviation of three replicates.  
 194 
When a one-way ANOVA test to compare maximum repression values at each tetO position was applied, 195 
only tet.I.15 through tet.I.17 showed a significant difference (P ≤ 0.0001) on downregulation of T7 196 
RNAP-driven expression (tet.I.14 falls at a transitional position (P ≤ 0.01)) (Fig. 2B).  There is little, if any, 197 
observable effect of the tetO position on downregulation when the tetO sequence is less than 14 bp 198 
downstream from the T7 promoter.  This phenomenon is best illustrated by the heat map in Figure 4A.  199 
Our results suggest one of two mechanisms for regulation may be at play: (1) that TetR blocks the 200 
binding of T7 RNAP, equally, up through position 13 or (2) that TetR prevents T7 polymerase from 201 
transitioning from initiation to elongation.  202 
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Figure 4. Statistical Analysis of tetO Positioning Effects on T7-Driven Expression. The maximum 
repression values calculated for both (A) linear and (B) circular templates were subject to an ordinary 
ANOVA analysis.  Adjusted P-values (alpha = 0.05) were converted to a heat map and plotted 
comparatively against each construct to demonstrate significance. 
 203 
Template Format Impacts TetR Binding to the TetO Sequence but Not Downregulation 204 
To investigate the effects of template format (linear versus circular) on tet regulation of T7 RNAP-driven 205 
expression, each construct was seamlessly cloned into the pY71 expression vector, as described in 206 
Materials and Methods.  Circular templates are differentiated from linear templates using the prefix 207 
pY71.  Each circular template was evaluated for expression in cell-free extract, as described for linear 208 
templates.  Different concentrations of TetR were added to reaction wells using an acoustic liquid 209 
handler.  Cell-free reactions were run for 12 h, expression curves were fit using a sigmoidal regression, 210 
and the maximum sfGFP values were used for further evaluation (Fig. 3A) 211 
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Figure 3. GFP Expression and TetR Dose-Response from Circular Template.  (A) GFP was expressed 
from 2 nM circular PY71-tet.I.3 template in 10 µL of cell-free extract containing varying concentrations 
of TetR.  Each trace represents the mean and standard deviation of three reactions. (A, inset) The 
expression curves shown in panel A were fit to a sigmoid regression.  The maximum expression values 
were rescaled and plotted against TetR concentration and a four parameter logistic curve fit was 
applied.  (B) The same analysis was performed for each tetO position and only the fits are shown.  
 212 
We again observed variation in maximum sfGFP expression between templates, ranging from 0.5 µM to 213 
4.4 µM in the absence of TetR.  Again, we tested two different preparations of each template with no 214 
TetR present (Fig. S4B).  When a one-way ANOVA test was applied to the expression data from lot 1, no 215 
pattern that might indicate an effect of tetO position on expression became apparent (Fig. S4D).  A two-216 
way ANOVA test was applied to the expression data of both lots in order to determine statistical 217 
significances in the difference in expression at each tetO position (Fig. S4F).  In contrast to linear 218 
template, a pattern of no significance running along the diagonal in Figure S4F was observed (with the 219 
exception of pY71Ntet.I.17).  However, at most positions there is no statistically significant difference in 220 
expression.  This may be attributed to the large standard deviations for the expression means of lot 2.  221 
Therefore, it is difficult to conclude that the variation in expression is necessarily due to tetO position 222 
alone, in circular template. 223 
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Expression values for circular template were rescaled as described for linear template.  This was also 224 
useful for the direct comparison of data from circular template with those from linear template.  225 
Rescaled expression values were plotted against TetR concentration to generate dose-response profiles 226 
for each tetO position.  Each dose-response profile was fit to a four parameter logistic regression curve 227 
(Fig. 3B) in order to obtain maximum repression values and IC
50
 values for TetR for each position (Table 228 
S2). 229 
As with linear template, a one-way ANOVA test comparing IC
50
 values for all positions, in circular 230 
templates, revealed no significant difference (P ≤ 0.0001), except for the IC
50
 values for PY71-tet.I.5 and 231 
PY71-tet.I.6 comparatively to each other and the other tetO positions.  Interestingly, a two-way ANOVA 232 
test, comparing IC
50
 values from circular and linear template, revealed a statistically significant 233 
difference.  Further, with the exception of tet.I.15 and tet.I.17, a t-test of individual IC
50
 values between 234 
the two template formats, at each tetO position, shows a statistically significant difference (P ≤ 0.05).  235 
This suggests that, while tetO position does not influence TetR binding, template format may affect TetR 236 
binding.  This is illustrated, qualitatively, by Figure 2A, which shows the relatively small variation in IC
50
 237 
values along tetO position within template format compared with the relatively greater variation in IC
50
 238 
values observed between template format.   239 
Even though TetR displays an unusually low background affinity for DNA (~10
5
 M
-1
) [28], we reasoned 240 
that some non-specific DNA binding might well account for the increased IC
50
 values in circular template, 241 
increasing the effective concentration required for downregulation.  In order to test this hypothesis, we 242 
added 2 nM PCR-amplified linear pY71 backbone to 2 nM linear tet.I.5 template in cell-free reactions, 243 
while varying TetR concentration (Fig. S5).  Our results showed that the IC
50
 value increased from 0.010 244 
± 0.002 µM to 0.029 ± 0.002 µM upon the addition of pY71 backbone DNA, a statistically significant 245 
increase (Welch’s t-test, p = 0.0006).  The IC
50
 value for circular template in this experiment was 0.073 ± 246 
0.047 µM, which is not statistically different from the IC
50
 value for linear template with linear pY71 247 
for use under a CC0 license. 
This article is a US Government work. It is not subject to copyright under 17 USC 105 and is also made available 
(which was not peer-reviewed) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity.
The copyright holder for this preprint. http://dx.doi.org/10.1101/614545doi: bioRxiv preprint first posted online Apr. 20, 2019; 
14 
 
backbone DNA (Welch’s t-test, p = 0.24).  These results suggest that non-specific binding of TetR to the 248 
vector backbone may indeed be responsible for the observed differences between linear and circular 249 
templates.  However, a t-test, applied to the IC
50
 values of tet.I.5 and pY71-tet.I.5 also shows no 250 
statistically significant difference (Welch’s t-test, p = 0.15).  Thus, we cannot rule out contribution from 251 
other factors. 252 
A one-way ANOVA test comparing TetR downregulation in circular template yielded results similar to 253 
that for linear template.  This, again, is best illustrated by the heat map in Figure 4B, showing no 254 
statistically significant (P ≤ 0.0001) reduction in repression when tetO is upstream of position 14.  A 255 
qualitative comparison of the heat maps in Figure 4 and the traces in Figure 2B show remarkably similar 256 
trends for both template formats.  This suggests that template format has little, if any, impact on tet 257 
regulation of T7 RNAP-driven expression, verifying our use of linear template to evaluate engineered T7-258 
based transcription factors. 259 
TetR Acts to Regulate T7-Driven Expression by Interfering with the Transition of T7 RNAP from 260 
Initiation to Elongation 261 
In order to further investigate the tet regulatory mechanism for T7 RNAP, we placed the tetO sequence 262 
at positions 18, 27, and -36. For positions 18 and 27, we predicted that the trend of decreased 263 
regulation at positions further downstream from position 14 would continue.  As expected, we observed 264 
nearly no downregulation at positions 18 and 27 (Fig. 5).  Evaluation of position -36, which is 265 
immediately upstream of the T7 promoter sequence, was intended to differentiate the aforementioned 266 
competing hypotheses: (1) that the mechanism of regulation was either due to competitive binding 267 
between TetR and T7 RNAP near the promoter region, or (2) that TetR prevents T7 RNAP from 268 
transitioning from initiation to elongation.  Interestingly, we found that, when the tetO sequence was 269 
placed immediately upstream from the T7 promoter sequence (tet.I.-36), TetR did not significantly 270 
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downregulate T7 RNAP-driven expression (Fig. 5), suggesting that tet regulates T7 RNAP-driven 271 
expression by preventing T7 RNAP from transitioning from initiation to elongation, rather than blocking 272 
T7 RNAP binding.  Our observations are supported by the findings of Iyer et al. [4] and are consistent 273 
with the kinetic model published by Skinner et al. [10].  274 
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Figure 5. The Effect of Additional tetO Positions on T7-Driven Expression in Cell-Free Extract. (A) 
Expression curves for each template type were fit to a sigmoid regression.  The maximum expression 
values were rescaled and plotted against TetR concentration and a four parameter logistic curve fit was 
applied.  (B) The maximum repression values for each construct, calculated by subtracting the minimum 
value from the maximum value for each logistic curve fit in panel A, were plotted as bar graphs with the 
tetO position indicated on the x-axis.  The template type is indicated in the legend. Each bar represents 
the mean and standard deviation of three replicates.  *Logistic curve fit for tet.I.27 yielded a negative 
maximum repression. 
 276 
Discussion 277 
Due to its orthogonality to bacterial host machinery, T7 RNAP is a powerful tool for gene circuit design, 278 
and regulating its activity is central to fine-tuning gene circuit function.  As such, understanding 279 
regulatory mechanisms for T7 RNAP are important to the design of engineered T7-based transcription 280 
factors that can be used in synthetic gene circuits. 281 
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Here we describe a rapid and cost-effective method to characterize promoter-operator combinations 282 
using cell-free protein synthesis and an acoustic liquid handler.  Using this method, we investigated the 283 
effect of proximity of the tetO sequence to the T7 promoter on the regulation of T7 RNAP-driven 284 
expression.  We observed that the absolute expression levels of sfGFP varied between templates, even 285 
when the same amount of template was added.  Therefore, we prepared a second lot of each template, 286 
and measured sfGFP expression in cell lysate.  While it may be tempting to conclude that the tetO 287 
position is accountable for the variation in expression based on a qualitative assessment from the 288 
patterns in the traces of Figures S4E and S4F, statistical analyses of the expression data (Fig. S4) indicate 289 
that the tetO position is not alone responsible for the variation in expression.  There are numerous 290 
factors, beyond minor variations in template sequence, that may be responsible for the observed 291 
variation.  One such culprit is template preparation.  Templates were prepared by the mini prep 292 
(Qiagen) method and small variations in the amount of salts carried over during template preparation 293 
may account, in part, for the variation in expression.  It is known that the salts magnesium and 294 
potassium, which is contained as 0.9 M potassium acetate in the neutralization buffer of the Qiagen 295 
miniprep kit, are among the most important parameters, along with template concentration, that affect 296 
the efficiency of cell-free protein synthesis [24,29].  Despite variation in expression, when the expression 297 
values were rescaled, consistent patterns emerged that are useful in promoter characterization.  298 
Our data comparing the IC
50
 values for TetR in both template formats raises the question of whether 299 
format influences the IC
50
 value and, by extension, TetR binding to the tetO sequence (Fig. 2A and S3).  300 
While our experiment of adding linear backbone DNA to linear template appears to at least partially 301 
explain the differences in IC
50
 values, a second explanation may be in play as well.   The crystal structure 302 
of the TetR homodimer reveals binding to the tetO sequence via N-terminal alpha helices, which occupy 303 
the major grooves of the operator, engaging with all but three base pairs of the sequence [30].  In its 304 
relaxed state, the periodicity of the DNA helix is 10.4 bp per turn [31].  However, under supercoiled 305 
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conditions, such as with circular DNA [32], the periodicity can vary between 10 to 11 bp turn [33], thus 306 
changing the width of the DNA grooves.  It is plausible that the difference in IC
50
 values we observed 307 
between template formats can reasonably be attributed to the use of circular versus linear template.  308 
The contribution from experimental variation, however, makes it difficult to identify a single conclusive 309 
explanation. 310 
In probing tetO position effects, we observed that T7 RNAP-driven expression is downregulated to the 311 
same degree when the tetO sequence is within 13 bp downstream from the T7 transcriptional start site 312 
(Fig. 3B) and that nearly no TetR downregulation is observed if the tetO sequenced is placed 313 
immediately upstream of the T7 promoter sequence (Fig. 5B).  These results suggest that the tet 314 
regulatory mechanism for T7 RNAP operates by disrupting the transcriptional cycle, as described by 315 
Skinner et al. [10], at the initiation phase.  316 
The transcriptional cycle, as described by Skinner et al. [10], proceeds through three phases: binding, 317 
initiation, and elongation (Fig. 6).  During the binding phase, T7 RNAP recognizes the T7 promoter.  318 
Binding to the promoter sequence is close to the diffusion-controlled limit, indicating a relatively strong 319 
affinity of T7 RNAP for the T7 promoter [34] (Fig. 6A).  Helix melting then occurs rapidly with the binding 320 
of the second ribonucleotide.  Single molecule kinetic studies [10] on T7 RNAP revealed that, during 321 
initiation, T7 RNAP undergoes several rounds of abortive transcription across the first 12 bases of the 322 
template (Fig 6B), producing short RNA transcripts.  Further, single molecule kinetics have shown that, 323 
during initiation, T7 RNAP favors dissociation (k
off
 = 2.9 s
-1
) over transitioning to elongation (k
for
 = 0.36 s
-
324 
1
) [10].  During initiation, T7 RNAP accommodates only three base pairs of the DNA-RNA heteroduplex 325 
within the active site of the enzyme [35].  This explains the relatively weak affinity of the T7 RNAP for 326 
the DNA template throughout the 12 bases that constitute initiation.  As T7 RNAP transitions from 327 
initiation to elongation (Fig. 6C), it undergoes a conformational change: the collapse of the promoter 328 
binding site and the formation of a channel, around the active site, that accommodates seven base pairs 329 
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of the DNA-RNA heteroduplex [9,36], as well as the formation of an N-terminal tunnel, allowing for the 330 
egress of the nascent RNA transcript [9].  Throughout elongation, processivity is increased significantly, 331 
indicating a relatively strong affinity of the T7 RNAP for the DNA template. 332 
 
Figure 6. Kinetic Scheme for T7 RNAP-Catalyzed Transcription.  (A) T7 RNAP binds to DNA template 
at the T7 promoter sequence.  (B) T7 RNAP then undergoes initiation, during which short transcripts 
(RNA
x
) of no greater than 12 nucleotides (x) are synthesized.  (C) After several rounds of abortive 
transcription, T7 RNAP enters elongation.  
 333 
Our results are in good agreement with the transcriptional model presented by Skinner et al. [10], and 334 
illustrated in Figure 6.  Consistent with the relatively weak affinity of T7 RNAP for the template during 335 
initiation, we observed that downregulation of T7 RNAP-driven expression is the strongest and identical,336 
irrespective of the tetO position, as long as it is within the first 13 bp downstream from the T7 promoter 337 
(Fig. 3B and Fig. 4).  TetR became less effective as tetO moved further downstream, consistent with T7 338 
RNAP entering elongation following base 12 of its transcript [10], and the enzyme’s strong affinity for 339 
the DNA template during this phase.  Finally, TetR was also not effective at downregulating expression 340 
when tetO was placed immediately upstream of the T7 promoter sequence (Fig. 5B), consistent with T7 341 
RNAP’s strong affinity for the T7 promoter.  342 
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Understanding the mechanism of repression for T7 RNAP using well characterized systems, such as the 343 
tet system, will allow for the design of more effective engineered T7-based transcription factors.  Our 344 
results suggest that the design of new repressor-based, T7-based transcription factors would be best 345 
narrowed to the initiation phase of T7 RNAP.  Indeed, since tet repression is one of the most effective in 346 
native promoter systems [23], our results suggest that placing operator sites outside of the 12 bp stretch 347 
consistent with initiation is likely futile unless additional mechanisms such as DNA looping [4] are 348 
employed.  We also showed that the method developed here, utilizing cell-free protein synthesis and 349 
linear template, can be used to rapidly evaluate any such new engineered T7-based transcription 350 
factors.  These results will assist in expanding the pallet of engineered T7-based transcription factors for 351 
the design of gene circuits.  352 
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